5-amino-1mq and cd38 inhibitor synergy nad+ Rapid Discovery of via DNA-Encoded Natural Product Library Screening Nicotinamide N-Methyltransferase in Cardiovascular Diseases:
Nicotinamide N Methyltransferase in Cardiovascular Diseases: Metabolic Regulator and Emerging Therapeutic Target The Pharmacology of CD38 NADase: An emerging target for cancer and aging diseases PMC Dual targeting of SLC25A51 and succinate dehydrogenase selectively depletes mitochondrial NAD+ to eradicate KRAS driven AML: Cell Metabolism Biological Functions and Therapeutic Potential of NAD+ Metabolism in Gynecological Cancers Nicotinamide N methyltransferase as a potential therapeutic target for neurodegenerative disorders: Mechanisms, challenges, and future directions ScienceDirect
Pay in 4 interest-free payments of $5.35 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9




